Catheter‐related and clinical complications associated with QDOT MICRO TM Ablation Catheter
Journal of Cardiovascular Electrophysiology · 2024
DOI: 10.1111/jce.16363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Jakrin Kewcharoen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA. Hauptthemen laut MEDLINE: Catheter Ablation, Cardiac Catheters, Equipment Design. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Introduction
The QDOT MICRO TM Ablation Catheter is a next‐generation ablation catheter that allows for high‐power ablation up to 90 watts.
Methods
We aimed to assess AE associated with the QDOT MICRO TM catheter using the MAUDE database. A MAUDE database search was conducted on May 25, 2024, to capture all AEs (since FDA approval) associated with this ablation catheter.
Results
A total of 302 AEs from November 23, 2022, to April 30, 2024, were reported including 148 (49%) catheter‐related issues and 154 (51%) clinical complications. Among the catheter‐related issues, physical catheter damage (74.3%, n = 110) was most common, followed by communication or display issue (10.8%, n = 16), irrigation issue (9.5%, n = 14), signal issue or artifact (3.4%, n = 5), and inaccurate temperature measurement (2.0%, n = 3). Regarding clinical complications, the most common AE was pericardial effusion (43.5%, n = 67), followed by char formation (11.7%, n = 18), catheter thrombosis (7.1%, n = 11), stroke (7.1%, n = 11), pericarditis (7.1%, n = 11), esophageal complications (6.5%, n = 10), phrenic nerve palsy (3.9%, n = 6), cardiac arrest (3.9%, n = 6), significant AV block (3.9%, n = 6), pulmonary vein stenosis (3.2%, n = 5), coronary artery spasm (1.3%, n = 2), and pulmonary embolism (0.6%, n = 1). There were 11 deaths (five related to esophageal complications, five related to cardiac arrest, and one related to pericardial effusion with cardiac tamponade).
Conclusion
As high‐power ablation strategy with novel ablation catheters is becoming more widely utilized, operators must be aware of potential catheter‐related issues and clinical complications that may arise. More data are needed to further evaluate risks of these complications to improve the catheter's safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.
- Division of Cardiology, Cardiac Arrhythmia Service, MercyOne Siouxland Heart and Vascular Center, Sioux City, Iowa, USA.
- Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Kansas City Heart Rhythm Institute and Research Foundation, Kansas City, Missouri, USA.
ORCID-Profile: Kuldeep Shah, Rahul Bhardwaj, Dhanunjaya Lakkireddy, Jalaj Garg
Zitieren
APA
Kewcharoen, J., Shah, K., Bhardwaj, R., Turagam, M. K., Contractor, T., Mandapati, R., Lakkireddy, D., & Garg, J. (2024). Catheter‐related and clinical complications associated with QDOT MICRO TM Ablation Catheter. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16363
Vancouver
Kewcharoen J, Shah K, Bhardwaj R, Turagam MK, Contractor T, Mandapati R, et al. Catheter‐related and clinical complications associated with QDOT MICRO TM Ablation Catheter. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16363
BibTeX
@article{Kewcharoen2024,
author = {Kewcharoen, Jakrin and Shah, Kuldeep and Bhardwaj, Rahul and Turagam, Mohit K and Contractor, Tahmeed and Mandapati, Ravi and Lakkireddy, Dhanunjaya and Garg, Jalaj},
title = {Catheter‐related and clinical complications associated with QDOT MICRO TM Ablation Catheter},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2024},
doi = {10.1111/jce.16363}
}
EUVIMED